Recent progress in microneme-based vaccines development against Toxoplasma gondii

다국어 초록 (Multilingual Abstract)

Toxoplasmosis is a cosmopolitan zoonotic disease, which infect several warm-blooded mammals. More than one-third of the human population are seropositive worldwide. Due to the high seroprevalence of Toxoplasma gondii infection worldwide, the resulting clinical, mental, and economical complications, as well as incapability of current drugs in the elimination of parasites within tissue cysts, the development of a vaccine against T. gondii would be critical. In the past decades, valuable advances have been achieved in order to identification of vaccine candidates against T. gondii infection. Microneme proteins (MICs) secreted by the micronemes play a critical role in the initial stages of host cell invasion by parasites. In this review, we have summarized the recent progress for MIC-based vaccines development, such as DNA vaccines, recombinant protein vaccines, vaccines based on live-attenuated vectors, and prime-boost strategy in different mouse models. In conclusion, the use of live-attenuated vectors as vehicles to deliver and express the target gene and prime-boost regimens showed excellent outcomes in the development of vaccines against toxoplasmosis, which need more attention in the future studies.

참고문헌 (Reference)

1 Pinzan CF, "Vaccination with recombinant microneme proteins confers protection against experimental toxoplasmosis in mice" 10 : e0143087-, 2015

2 Wang T, "Vaccination with recombinant adenovirus expressing multi-stage antigens of Toxoplasma gondii by the mucosal route induces higher systemic cellular and local mucosal immune responses than with other vaccination routes" 24 : 12-, 2017

3 Yan HK, "Vaccination with a DNA vaccine coding for perforin-like protein 1 and MIC6 induces significant protective immunity against Toxoplasma gondii" 19 : 684-689, 2012

4 Yan HK, "Toxoplasma gondii: protective immunity against experimental toxoplasmosis induced by a DNA vaccine encoding the perforin-like protein 1" 128 : 38-43, 2011

5 Wang H, "Toxoplasma gondii: protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice" 122 : 226-232, 2009

6 Gong P, "Toxoplasma gondii: Protective immunity induced by a DNA vaccine expressing GRA1 and MIC3 against toxoplasmosis in BALB/c mice" 166 : 131-136, 2016

7 Dautu G, "Toxoplasma gondii: DNA vaccination with genes encoding antigens MIC2, M2AP, AMA1 and BAG1 and evaluation of their immunogenic potential" 116 : 273-282, 2007

8 Liu MM, "Toxoplasma gondii microneme protein 8 (MIC8) is a potential vaccine candidate against toxoplasmosis" 106 : 1079-1084, 2010

9 Peng GH, "Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice" 27 : 6570-6574, 2009

10 Xiang W, "The location of invasion-related protein MIC3 of Toxoplasma gondii and protective effect of its DNA vaccine in mice" 166 : 1-7, 2009

11 Ismael AB, "The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis" 71 : 6222-6228, 2003

12 Li ZY, "Synergy of mIL-21 and mIL-15 in enhancing DNA vaccine efficacy against acute and chronic Toxoplasma gondii infection in mice" 32 : 3058-3065, 2014

13 Peng GH, "Sequence variation in Toxoplasma gondii MIC4 gene and protective effect of an MIC4 DNA vaccine in a murine model against toxoplasmosis" 9 : 1463-1468, 2010

14 Tao Q, "Protective immunity induced by a DNA vaccine-encoding Toxoplasma gondii microneme protein 11 against acute toxoplasmosis in BALB/c mice" 112 : 2871-2877, 2013

15 Fang R, "Protective immune response in BALB/c mice induced by a suicidal DNA vaccine of the MIC3 gene of Toxoplasma gondii" 164 : 134-140, 2009

16 Yu L, "Protective effect of a prime-boost strategy with plasmid DNA followed by recombinant adenovirus expressing TgAMA1 as vaccines against Toxoplasma gondii infection in mice" 61 : 481-486, 2012

17 Lee SH, "Protection induced by virus-like particles containing Toxoplasma gondii microneme protein 8 against highly virulent RH strain of Toxoplasma gondii infection" 12 : e0175644-, 2017

18 Yang D, "MIC3, a novel cross-protective antigen expressed in Toxoplasma gondii and Neospora caninum" 114 : 3791-3799, 2015

19 Qu D, "Induction of protective immunity by multiantigenic DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice" 166 : 220-227, 2009

20 Nie H, "Immunogenicity and protective efficacy of two recombinant pseudorabies viruses expressing Toxoplasma gondii SAG1 and MIC3 proteins" 181 : 215-221, 2011

21 Zheng B, "Immuno-efficacy of a T. gondii secreted protein with an altered thrombospondin repeat (TgSPATR) as a novel DNA vaccine candidate against acute toxoplasmosis in BALB/c mice" 8 : 216-, 2017

22 Lourenco EV, "Immunization with MIC1 and MIC4 induces protective immunity against Toxoplasma gondii" 8 : 1244-1251, 2006

23 Yuan ZG, "Evaluation of protective effect of pVAX-TgMIC13 plasmid against acute and chronic Toxoplasma gondii infection in a murine model" 31 : 3135-3139, 2013

24 Qu D, "Evaluation of protective effect of multiantigenic DNA vaccine encoding MIC3 and ROP18 antigen segments of Toxoplasma gondii in mice" 112 : 2593-2599, 2013

25 Fang R, "Evaluation of immune responses induced by SAG1 and MIC3 vaccine cocktails against Toxoplasma gondii" 187 : 140-146, 2012

26 Ghaffarifar F, "Eukaryotic plasmids with Toxoplasma gondii dense granule antigen (GRA5) and microneme 3 (MIC3) genes as a cocktail DNA vaccine and evaluation of immune responses in BALB/C mice" 3 : 121-, 2014

27 Beghetto E, "A combination of antigenic regions of Toxoplasma gondii microneme proteins induces protective immunity against oral infection with parasite cysts" 191 : 637-645, 2005

28 Yin H, "A Toxoplasma gondii vaccine encoding multistage antigens in conjunction with ubiquitin confers protective immunity to BALB/c mice against parasite infection" 8 : 498-, 2015